Successful JC virus-targeted T-cell therapy for progressive multifocal leukoencephalopathy in a lung transplant recipient
- 12 April 2022
- journal article
- editorial
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 41 (7) , 991-996
Abstract
No abstract availableFunding Information
- Fondazione per la Ricerca Biomedica (CP2_10/2018)
- Regione Lombardia (2526393)
- Ministero della Salute (RCR 08071519, RF-2019-12371492)
This publication has 8 references indexed in Scilit:
- Adoptive Transfer of JC Virus‐Specific T Lymphocytes for the Treatment of Progressive Multifocal LeukoencephalopathyAnnals of Neurology, 2021
- Treatment of Progressive Multifocal Leukoencephalopathy Using Immune RestorationNeurotherapeutics, 2020
- Allogeneic BK Virus–Specific T Cells for Progressive Multifocal LeukoencephalopathyNew England Journal of Medicine, 2018
- Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directionsExpert Review of Anti-infective Therapy, 2015
- European perspective on human polyomavirus infection, replication and disease in solid organ transplantationClinical Microbiology and Infection, 2014
- Progressive multifocal leukoencephalopathy in transplant recipientsAnnals of Neurology, 2011
- Treatment of solid organ transplant recipients with autologous Epstein Barr virus–specific cytotoxic T lymphocytes (CTLs)Blood, 2006
- Testing for Polyomavirus Type BK DNA in Plasma to Identify Renal-Allograft Recipients with Viral NephropathyNew England Journal of Medicine, 2000